1. The turnover of fibrinogen was studied in twenty-eight patients after moderate and major surgical operations and in a contrast group of thirteen patients suffering from miscellaneous chronic disorders.
healthy and the remainder suffering from miscellaneous chronic disorders. A description of both groups is given in Tables 1 and 2. Before and for 10 days after the administration of 1251-labelled fibrinogen, the thyroid gland was saturated by the oral administration of 150 mg KI daily. In four members of the surgical group 1251-labelled fibrinogen was given 7 days before the day of operation in order that a pre-operative study might be made. In the remainder of the surgical group 1251-labelled fibrinogen was given not more than 24 h after operation..
125I-labelled fibrinogen preparation
Initially commercially available material was used. This comprised fibrinogen prepared by Kabi Pharmaceuticals, Stockholm, Sweden, and iodinated at The Radiochemical Centre, Amersham, Bucks. This material was supplied in a freeze-dried form in ampoules containing 0,7-1,0 mg of fibrinogen labelled with 100 jlCi of 1251. Latterly, fibrinogen was prepared in our laboratory from a single selected donor by using the method described by Regoeczi (1970) , and iodinated by the method of McFarlane (1963) . The mean percentage of the circulating plasma radioactivity which could be clotted by thrombin was 92·4% (SD 1,3) for the first preparation and 94·9% (SD 1,1) for the latter preparation.
Radioactivity (50-100 jlCi) was given to each patient and the study was continued for up to 12 days after its administration.
Plasma radioactivity
The method was that of Regoeczi (1967) , slightly modified. Approx. 7 ml of blood was delivered into a plastic tube containing 40 mg of dry EDTA (Stayne Laboratories Ltd) and 0·05 ml of trasylol (aprotinin), 5000000 IU/ml (Bayer, Germany). After centrifugation for 10 min at 550 g, duplicate 1·0 ml plasma samples were added to plastic counting tubes containing 2·0 ml of phosphate-saline buffer pH 6·0 and 40 NIH units of bovine thrombin (Leo Pharmaceuticals Ltd, Denmark). The samples were then left at room temperature for a minimum of 2 h, after which they were kept at 4°until taken for radioactive assay. Measurements of radioactivity were made in a well-type scintillation counter, before (count I) and after (count II) the removal of the clot with a stainless-steel needle. The activity in the 'clottable' fraction of plasma was represented by count I -count II and the percentage total coagulability of the preparation in vivo by [(count I-count II)/count I] x 100. The 'non-clottable' radioactivity was further analysed into protein-bound and non-protein-bound (iodide) fractions by adding 3·0 ml of 20% (w/v) trichloroacetic acid to the sample after completing count II, removing the precipitate by centrifugation and measuring the activity in a 3·0 ml sample of supernatant fluid (count III).
The mean percentage error in fifty randomly selected pairs of duplicate samples measured for radioactivity in the 'clottable' fraction was 1'13% (range 0-4'8%). This error was calculated for duplicate results, a and b, as [(a-m) /m] x 100%, where m = 1(a+ b).
Plasma volume
The plasma volume was measured at the time of administration of 1251-labelledfibrinogen by an isotope-dilution technique. The radioactivity in a sample obtained from a known weight of 1251-labelled fibrinogen which had been diluted to 250 ml in alkaline urea solution (3'33 M-urea in 0·1 M-KOH) was compared with the plasma radioactivity 15 min after the injection of a known weight of 12sI-labelled fibrinogen. The accuracy of this technique was limited by the fact that only a single 15 min observation was made and further by the presence of nonprotein-bound radioactive iodine in the fibrinogen preparation. However. the amount of radioactivity in the 15 min sample present in a non-protein-bound form rarely exceeded 5% of the total plasma radioactivity and it was felt that an adequate estimate of the plasma fibrinogen pool could be made.
Plasma fibrinogen concentration
The plasma fibrinogen concentration was measured gravimetrically by employing a modification of the method of Fearnley & Chakrabarti (1966) . For this procedure the fibrin sample was washed successively for 30 min periods while still attached to the steel needle. first in normal saline then in water. The fibrin was separated from the needle by using pointed forceps and washed in acetone for 30 min. After the acetone was drained off, the clot was baked in a constant-temperature oven at 90°for 15 h. Clots were weighed immediately after removal from the oven by using a Mettler type H16 spring balance.
, By using this method the mean percentage error in eighty such duplicate samples selected at random was 2·07% (range 0-5'39%), and the mean value obtained in a study of seventy healthy young adults aged 20-35 years was 264 mg/IOO ml of plasma (SD 43, 9) .
Fibrin degradation products (FDP)
The Wellcome FDP assay kit was used (Wellcome Reagents, Beckenham, Kent) in conjunction with a microtitre set (Flow Laboratories, Ayrshire).
Results were read independently by two observers neither of whom knew the source of the samples. Independent agreement on the reading was obtained in approximately 80% of tests. If the readings differed by no more than one serial dilution the mean was taken. On the rare occasion that the reading differed by more than one serial dilution the test was set up again.
Calculations 12sI-labelled fibrinogen survival was obtained from serial studies of the activity in the 'clottable' fraction of plasma (count I-count II). All values subsequent to the initial 15 min estimation and up to 10 days afterwards were expressed as a percentage of the initial value and the results were plotted graphically on a semi-logarithmic scale. After an equilibration period of 20-40 h the radioactivity declined exponentially.
The half-life and daily loss of 12sI-labelled fibrinogen from the plasma, expressed as a percentage of the plasma pool, were then calculated according to the three compartmental model of Matthews (1957) , as adapted for digital computing by Regoeczi (1970) .
Detection of deep-vein thrombosis of the legs
In twenty-one patients in the post-operative group daily surface counts were performed along the medial aspect of both legs until 7 days after operation; the presence of deep-vein thrombosis was diagnosed according to the criteria of Negus, Pinto, Le Quesne, Brown & Chapman (1968) .
RESULTS

Contrast group
The results obtained in the contrast group are summarized in Table I . Patients in this group frequently possessed an elevated plasma fibrinogen concentration (reflecting the presence of a chronic disease process) and hence the values for the plasma fibrinogen pool and absolute plasma loss are correspondingly raised. Table 2 is a synopsis of the results obtained in the four patients who were given 125I-labelled fibrinogen before operation to obtain pre-operative measurements. The plasma volume determinations were made at the time of administration of the fibrinogen preparation and some change may have occurred during the post-operative study period. However, it will be noted that after operation there was a marked decrease in the half-life in every patient, with the mean value falling from 95·0 h pre-operatively to 53·0 h post-operatively. Despite this shortened survival, the mean plasma fibrinogen concentration increased from 452 mg/IOO ml before operation to 706 mg/IOO ml after operation. An illustrative study (patient 27) is shown in Fig. I which depicts the decline in 'clottable' activity and the decline in specific radioactivity (c.p.m.jrng of fibrinogen). After the operation the slope for specific radioactivity diverges from the slope for 'clottable' activity demonstrating that the increased production of fibrinogen during this period is more than adequate to compensate for the enhanced loss. Table 3 summarizes the post-operative studies performed in twenty-eight patients. Despite wide variation, the mean values for half-life (60,1 h) fractional plasma loss (40'1 % per 24 h) and absolute loss per 24 h (7,6 g or 116·6 mg/kg body weight) are markedly different from the corresponding values in the contrast group (P<O·OOI). When it is remembered that the normal total intravascular fibrinogen pool is of the order of 6 g, the magnitude of these daily losses is more readily perceived. Although the degree of enhancement appears to bear some relationship to the severity of the operation, even in the group of patients undergoing the relatively minor operation of cholecystectomy, there was significant shortening of the mean half-life (P < 0'005) and increase in the mean fractional plasma loss (P<O·OOI), compared with values for the contrast patients. Fig. 2 shows the mean survival curves in the contrast and surgical groups. To compare the distribution of the 'clottable' radioactivity between intravascular and extravascular compartments, the linear part of the curves has been extrapolated back to the axis. It will be seen that a significantly greater amount of the isotope was found extravascularly in the post-operative group (33% compared with 23%). The half-life for the periods from the second to the fifth days and from the fifth to the tenth days have been analysed separately. There was a slight but significant increase in the half-life in the latter period (P<0·025) but, even so, the half-life remains considerably shortened at the end of the first week after operation.
Surgical group
In view of the report by Jeyasingh, Maurer, Rosengarten & Verma (1970) that the development of deep-vein thrombosis of the legs is associated with a detectable increase in the rate of disappearance of 125I-labelled fibrinogen from the blood, a retrospective analysis of those patients who were examined daily by surface counting of the legs was done. Of the twenty-one patients investigated, four developed deep-vein thrombosis of the leg (patients 3, 12, 18 and 19) . Neither with respect to the overall half-life nor to the daily observations of 'clottable' activity could they be distinguished from the other members of the post-operative group. 
DISCUSSION
In the thirteen members of the contrast group the results for the half-life, the distribution of the dose between intravascular and extravascular compartments and the plasma loss per 24 h expressed as a percentage of the intravascular pool, are similar to results obtained in healthy subjects by Takeda (1966) and Regoeczi & Stannard (1969) , and in subjects with miscellaneous chronic disorders by Baker, Rubenberg, Dacie & Brain (1968) . This supports the use of these 125I-labelled fibrinogen preparations for metabolic studies and the employment of this contrast group of patients as a basis for comparison.
This study has demonstrated a marked decrease in the half-life of plasma 125I-labelled fibrinogen after moderate and major surgical procedures. Izak, Galewski & Eyal (1967) in their studies on the hypercoagulable state estimated the half-life of 131I-labelled fibrinogen in nineteen patients after a variety of surgical procedures. In twelve patients a decrease in the half-life was reported; in seven of these the half-life was less than 70 h compared with a mean value of 101 h (range 92-113 h) in a control group. Atkins & Hawkins (1969) studied the half-life of 125I-labelledfibrinogen employing whole plasma radioactivity measurements in an uncontrolled group of twenty patients after unspecified surgical procedures. They found the mean half-life to be 78 h with 25% of their patients having values of less than 66 h. A third study was reported by Davies, Liljedahl & Reizenstein (1970) . Sixteen patients undergoing orthopaedic operations were investigated with 125I-labelledfibrinogen and both plasma radio-activity and whole body counts were made. Their group of patients included eight young patients mostly with knee injuries and eight elderly patients mostly with fractures ofthe femur. The plasma half-life was found to be shortened and the whole body half-life prolonged with abnormally large amounts of radioactivity outside the circulating plasma, presumably in the form of wound or intravascular fibrin. This important study concluded that the actual amount of protein catabolized/day was increased to between 2 and 3 times normal in both the young and elderly patients.
The group of patients in the present study underwent moderate and major surgical operations and, it would be reasonable to suggest, underwent a greater degree of surgical trauma than the patients in the study of Davies et al. (1970) . Although none developed overt primary or secondary haemorrhage, it is probable that movement of fibrinogen-containing body fluids into viscera or body cavities produced a significant contribution to the total plasma loss, particularly in those undergoing surgery of the gastro-intestinal tract. In this context the study of gastro-intestinal protein loss after surgery by Hoedt-Rasmussen & Jarnum (1961) is relevant By using the 131I-labelled PVP technique in the immediate post-operative period no abnormal gastro-intestinal losses were observed in eight out of eleven patients undergoing a variety of (mainly abdominal) surgical procedures. However, three patients gave abnormal results after partial gastrectomy.
Irrespective of the sites of the abnormal loss, the quantitative estimates of fibrinogen metabolism provided by this study are of inherent interest. Normally about 25% of the plasma fibrinogen pool is catabolized each day, producing an absolute loss of the order of31 mg day"! kg-1 (Takeda, 1966) . In the post-operative group studied here, the mean absolute value was 117 mg day -1 kg -1 with a range of 36-242 mg day -1 kg -1. It is striking that patients in the higher range continued in the second week after operation to lose as much as 10-15 g of fibrinogen from the plasma each day, an amount that approaches twice the normal intravascular fibrinogen pool. In this category of patient the loss was matched by a nearly tenfold increase in hepatic synthesis. The behaviour of fibrinogen in this context provides a noteworthy contrast with that of albumin. After operation the plasma fibrinogen concentration rises (Warren, Amdur, Belko & Baker, 1950; Godal, 1962) , whereas that of albumin falls (Cuthbertson & Tompsett, 1935) . Loss of albumin into the wound after operation has been reported by Mouridsen (1967 Mouridsen ( , 1969 and although most experimental studies suggest that there is a slight increase in albumin synthesis after injury, in contrast with fibrinogen this appears inadequate to maintain the normal plasma concentration. Although studies in subjects given preparations of both fibrinogen and albumin would be necessary to pursue the point further, it would seem that in the post-operative period the absolute plasma loss of fibrinogen may at times approach or even exceed the absolute loss of albumin. Certainly in this study the fibrinogen loss often exceeded the albumin losses found by Mouridsen (1967) in patients after simple mastectomy, although they fell short of the values reported by Birke, Liljedahl, Plantin & Wetterfors (1959) in patients undergoing more comparable types of operation.
It is interesting to speculate whether this enhanced loss of fibrinogen might be an indication of disseminated intravascular coagulation (DIC). Certainly tissue damage, hypoxaemia and hypotension are all associated with the pathogenesis of this syndrome, occurring regularly during major surgical procedures. Survival studies with labelled fibrinogen and measurements of fibrin degradation products (FDP) and plasma fibrinogen concentration can in general be expected to reveal characteristic abnormalities in the presence of this condition. Unfortunately, for reasons given below, the interpretation of all three parameters is made difficult in the postoperative situation. First, the abnormally rapid disappearance of 125I-labelled fibrinogen relates to an abnormal loss or consumption at one or more of a number of possible sites. Second, the appearance in the serum of FDP during the post-operative period is a regular occurrence and may reflect the routine proteolysis of a wound fibrin plug or pathological plasmin production after DIC. On the basis of studies by Ruckley Copland, Redpath, Scott & Cash (1970) a quantitative distinction can probably be made between normal and abnormal rise of FDP after operation. However, this does not exclude the possibility of occult DIe which is insufficientto produce florid changes in the circulating blood, but is nonetheless sufficient to embarrass the micro-circulation in the vital organs of precariously balanced patients. Third, this study clearly shows that the plasma fibrinogen concentration is not only maintained but may actually increase during a period of greatly elevated loss.
In the presence of normal liver function defibrination can only be achieved by sudden and massive consumption of fibrinogen and it is important to realize that the presence of a normal or even elevated fibrinogen concentration cannot exclude the presence of DIC. One patient in the study (patient 38, see Fig. 3 ) immediately after a lengthy aorto-iliac disobliteration, did show an unusually rapid disappearance of 12SI-labelled fibrinogen with degrees of fall in plasma fibrinogen concentration and rise in FDP concentrations much greater than is usually seen and it is tentatively suggested that the most satisfactory explanation of the changes observed was a self-limiting period of DIC. A clearer understanding of this important aspect of post-operative metabolism will depend on further studies with a more thorough analysis of clotting factors and by the use of experimental models as in the dog studies by Lim, Appelgren, Bergentz & Leandoer (1969) .
Finally it should be mentioned that no correlation was observed in this study between the decline in blood 12sI-labelIed fibrinogen and the development of venous thrombosis in the legs. Although it is unlikely that, at a time when the turnover of fibrinogen is so greatly increased, the consumption of fibrinogen in a localized venous thrombosis is sufficient to alter significantly the biological half-life, it should be emphasized that this review was made retrospectively and the findings of Jeyasingh et al. (1970) require further elucidation.
